Our service
We offer you support from the selection of the right platform / broker to the first trade. With responsibility, transparency and foresight, we train investors in stock and options trading from the first purchase to the finished investment strategy.
TradeStation Support
Users worldwide use this leading trading platform for their analyses. Everything is integrated here – from screening to optimizing trading strategies.
Seminars & Webinars
Take advantage of our regular training courses and discover completely new trading approaches – option and stock setups defined and explained in detail for each trend.
Interactive Brokers
All the potential that IB and the TWS platform offer – numerous factors and good support open completely new horizons.
Platform Training and Setups
You will learn how to test new strategies, products, exchanges and order types.
Use unique trading tools – real-time charts, executions, market depth, option pricing, price/risk analysis, and much more
Learn how to get started with the Trader Workstation in simple steps.
The structure of the seminar allows participation even for beginners who have no experience with the platform. Familiarize yourself with the market dynamics of new exchanges and products. Test your IB API trading solutions.
Our services at a glance:
- Individual training online incl. recording
- Individually adapted to your needs
- Prefabricated templates
- Setup of the Trader Workstation in the desktop version, the Webtrader and the mobile app
- Introduction to account management and all trading reports
TradeVola – Our videos for the perfect introduction to trading with financial products
Follow our YouTube-Channel:
Top Categories / Features / Services
Introduction to Options Trading
Learn how to trade options in simple steps. This is regarded as a supplement to equity trading and as an independent strategy approach.
Get exclusive access to our recorded webinars + live webinars
Account opening TradeStation Global
Our support team will guide you through all the steps of opening an account with TradeStation Global, and will be available to you at all times. Take advantage of the possibilities of this professional trading platform now and enter into fully automated trading.
Account Opening Interactive Brokers
Use all the potential that IB and the TWS platform offers. We offer daily telephone support for all technical and professional questions regarding account opening and the platform. Furthermore, we will be happy to answer all your questions about your settlements and trade evaluations.
Blog
Once a week we present an exciting topic of the international trade markets. The focus of our research is always closely related to profitable opportunities in the market. When searching for exciting investment opportunities, we scan both the leading market news and the markets themselves. We always present the topic of our articles paired with an investment simulated on the TradeStation.
Is Beyond Meat about to shoot 23% higher?
In the last 12 months, Beyond Meat’s stocks have decreased by almost 30%, while Kraft Heinz’s stocks have increased by more than 30%.
Does this gap suggest that investors are more impressed by Kraft Heinz’s turnaround prospects than by the growth potential of Beyond Meat? Let’s take a closer look at both companies to find out.
Bilibili (BILI) reports Q2 loss and peak revenue estimates
Bilibili, which is part of the Zacks Internet services industry, reported revenues of $370.50 million for the quarter ending June 2020, exceeding the Zacks consensus estimate by 2.91%.
This compares to the previous year’s revenue of $225.43 million. The company has exceeded the consensus revenue estimates three times over the last four quarters.
Opioid crisis: What’s up with the fraud allegations?
Opioid manufacturers and distributors such as Teva, Allergan, Mallinckrodt MNK, Johnson & Johnson JNJ and Amneal Pharmaceuticals are regularly accused of exacerbating the country’s opioid epidemic through the manufacture and sale of addictive prescription painkillers.
Opioid drugs such as morphine, codeine, oxycodone and fentanyl, which are marketed by these companies and used as analgesics, have a high potential for abuse. The use of these opioid-based drugs is strictly controlled by the FDA.